| Ibrutinib, but not zanubrutinib, induces platelet receptor shedding of GPIb-IX-V complex and integrin αIIbβ3 in mice and humans G Dobie, FA Kuriri, MMA Omar, F Alanazi, AM Gazwani, CPS Tang, ... Blood advances 3 (24), 4298-4311, 2019 | 55 | 2019 |
| New generation drugs for treatment of multiple myeloma F Alanazi, FAA Kwa, G Burchall, DE Jackson Drug discovery today 25 (2), 367-379, 2020 | 45 | 2020 |
| Amelioration of human acute lymphoblastic leukemia (ALL) cells by ZnO-TiO2-Chitosan-Amygdalin nanocomposites AY Elderdery, B Alzahrani, F Alanazi, SMA Hamza, AME Elkhalifa, ... Arabian Journal of Chemistry 15 (8), 103999, 2022 | 11 | 2022 |
| Combined GSTT1 null, GSTM1 null and XPD Lys/Lys genetic polymorphisms and their association with increased risk of chronic myeloid leukemia EK Abdalhabib, DE Jackson, B Alzahrani, EM Elfaki, A Hamza, F Alanazi, ... Pharmacogenomics and Personalized Medicine, 1661-1667, 2021 | 9 | 2021 |
| Red Blood Cell Alloimmunization and Autoimmunization in Blood Transfusion‐Dependent Sickle Cell Disease and β‐Thalassemia Patients in Al‐Ahsa Region … FA Kuriri, A Ahmed, F Alanazi, F Alhumud, M Ageeli Hakami, ... Anemia 2023 (1), 3239960, 2023 | 8 | 2023 |
| Synthesis, Characterization, and Antimicrobial and Antiproliferative Effects of CuO-TiO2-Chitosan-Escin Nanocomposites on Human Leukemic MOLT4 Cells AY Elderdery, AH Alhamidi, AME Elkhalifa, MM Althobiti, N Eltayeb Omer, ... Nanomaterials 12 (21), 3753, 2022 | 8 | 2022 |
| IL-10 rs1800896 polymorphism: a risk factor for adult acute lymphoblastic leukemia EK Abdalhabib, B Alzahrani, M Saboor, A Hamza, EM Elfaki, F Alanazi, ... Pharmacogenomics and Personalized Medicine, 809-815, 2022 | 8 | 2022 |
| Association of TNF–α rs1800629 with Adult Acute B-Cell Lymphoblastic Leukemia EK Abdalhabib, A Algarni, M Saboor, F Alanazi, IK Ibrahim, AH Alfeel, ... Genes 13 (7), 1237, 2022 | 6 | 2022 |
| Synthesis of nickel cobalt-codoped tin oxide nanoparticles from Psidium guajava with anticancer properties AY Elderdery, B Alzahrani, AA Alabdulsalam, F Alanazi, SMA Hamza, ... Arabian Journal of Chemistry 16 (2), 104481, 2023 | 5 | 2023 |
| Synthesis and characterization of ZnO–TiO2–chitosan–escin metallic nanocomposites: Evaluation of their antimicrobial and anticancer activities AY Elderdery, AH Alhamidi, AME Elkhalifa, MM Althobiti, EMA Tebien, ... Green Processing and Synthesis 11 (1), 1026-1039, 2022 | 5 | 2022 |
| mice lacking PECAM-1 and Ceacam1 have enhanced platelet secretion and thrombus growth: novel link with PAR4 FA Kuriri, G Burchall, F Alanazi, J Antonipillai, G Dobie, N Beachemin, ... Thrombosis and Haemostasis 122 (06), 961-973, 2022 | 4 | 2022 |
| Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins EK Abdalhabib, DE Jackson, B Alzahrani, E Elfaki, A Hamza, F Alanazi, ... Blood Coagulation & Fibrinolysis 33 (3), 149-152, 2022 | 4 | 2022 |
| Increased risk of acute lymphoblastic leukemia in adult patients with GSTM1 null genetic polymorphism EK Abdalhabib, B Alzahrani, F Alanazi, A Algarni, IK Ibrahim, ... Pharmacogenomics and Personalized Medicine, 227-234, 2022 | 3 | 2022 |
| Frequency of Duffy, Kidd, Lewis, and Rh Blood Group Antigens and Phenotypes Among Donors in the Al-Ahsa Region, Saudi Arabia. FA Kuriri, A Ahmed, F Alhumud, F Alanazi, EK Abdalhabib Clinical Laboratory 70 (7), 2024 | | 2024 |
| Enhanced apoptotic activity of Pluronic F127 polymer-encapsulated chlorogenic acid nanoparticles through the PI3K/Akt/mTOR signaling pathway in liver cancer cells and in vivo … F Alanazi, AY Elderdery, B Alzahrani, NAN Alzerwi, MM Althobiti, ... e-Polymers 23 (1), 20230053, 2023 | | 2023 |
| Carfilzomib potentiates platelet activation and thrombus growth FMA Alanazi, I Goncalves, K Burbury, F Kwa, G Dobie, F Kuriri, ... Journal of Blood Disorders & Transfusion 13 (8), 1-7, 2022 | | 2022 |
| Age- and Gender-Independent Association of XRCC1 Arg399Gln Polymorphism with Chronic Myeloid Leukemia EK Abdalhabib, DE Jackson, B Alzahrani, E Elfaki, A Hamza, ... International Journal of General Medicine, 8231-8236, 2021 | | 2021 |
| Effects of multiple myeloma therapy on haemostasis and thrombosis FMA Alanazi RMIT University, 2020 | | 2020 |
| Lenalidomide and dexamethasone enhanced platelet activation and in vitro thrombus formation under arterial flow F Alanazi ISTH Academy, 2019 | | 2019 |
